Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
2013 ◽
Vol 28
(1)
◽
pp. 33-43
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 15
(6)
◽
pp. 3473-3478
◽
2014 ◽
Vol 9
(2)
◽
pp. 451-455
◽
Keyword(s):
2015 ◽
Vol 15
(1)
◽
2013 ◽
Vol 42
(10)
◽
pp. 1576-1584
Keyword(s):